As Per the Research Report, the Size of the Europe Intraocular Lens Market is valued at USD xx million in 2019 and expected to grow at a CAGR of xx.x%, to reach USD xx million by 2024 during the forecast period 2019-2024.
Intraocular lens (IOL) is a lens implanted in the eye for cataracts or myopia treatment. The most common type of IOL is the pseudophakic IOL and is implanted during cataract surgery, after the cloudy eye's natural lens (colloquially called a cataract) has been removed. This provides the same light focusing function as the natural crystalline lens. The other type of IOL is a phakic intraocular lens (PIOL), which is a lens which is placed over the existing natural lens, and is used in refractive surgery to change the eye's optical power as a treatment for myopia, or nearsightedness.
Increase in geriatric population vulnerable to ocular conditions, growing prevalence of cataract, and increase in initiatives taken by government to eliminate avoidable blindness are the major factors driving the market. However, unfavorable reimbursement policies and complications such as refractive errors are expected to be a major constraint.
Europe Intraocular Lens Market has been segmented and sub-segmented into the following categories
On the basis of region, Europe is assumed as developed market and is anticipated to witness significant growth in the forecast period.
Prominent Companies leading the Europe Intraocular Lens Market Profiled in the Report are Johnson & Johnson, Valeant, Carl Zeiss Meditec AG, Rayner, Alcon, Inc. (division of Novartis AG), EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical, PhysIOL s.a., Calhoun Vision Center, and Oculentis GmBH.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Material
5.1.1 Introduction
5.1.2 Polymethylmethacrylate (PMMA)
5.1.3 Silicone
5.1.4 Hydrophobic Acrylic
5.1.5 Y-o-Y Growth Analysis, By Material
5.1.6 Market Attractiveness Analysis, By Material
5.1.7 Market Share Analysis, By Material
5.2 Type
5.2.1 Introduction
5.2.2 Monofocal Intraocular Lens
5.2.3 Premium Intraocular Lens
5.2.3.1 Toric Intraocular Lens
5.2.3.2 Multifocal Intraocular Lens
5.2.3.3 Accommodating Intraocular Lens
5.2.3.4 Others
5.2.3.4.1 Blue Light Filtering Intraocular Lens
5.2.3.4.2 Phakic Intraocular Lens
5.2.3.4.3 Aspheric Intraocular Lens
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End-User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Ambulatory Surgery Centers
5.3.4 Ophthalmology Clinics
5.3.5 Eye Research Institutes
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Material
6.1.3.3 By Type
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Material
6.1.4.3 By Type
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Material
6.1.5.3 By Type
6.1.5.4 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Johnson & Johnson
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Carl Zeiss Meditec AG
8.3 Rayner
8.4 EyeKon Medical, Inc
8.5 HumanOptics AG
8.6 STAAR Surgical
8.7 HOYA GROUP
8.8 Alcon, Inc.
8.9 Valeant
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
